Xiankun Tong

State Key Laboratory Of Drug Research, 555 ZuChongZhi Road
Shanghai, 201203, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Natural product-based Ebola virus entry inhibitors targeting the viral glycoprotein: A combined computational and experimental study.

Natural product-based Ebola virus entry inhibitors targeting the viral glycoprotein: A combined computational and experimental study.

Journal: Antiviral research

Published: March 25, 2026

A novel entry inhibitor targeting the stalk domain of the hemagglutinin of H1N1.

A novel entry inhibitor targeting the stalk domain of the hemagglutinin of H1N1.

Journal: Acta pharmaceutica Sinica. B

Published: March 18, 2025

Discovery of novel Ebola entry inhibitors with 1,2,3,4-tetrahydroisoquinoline-3-carboxamide based on (3S,4aS,8aS)-2-(3-amino-2-hydroxypropyl) decahydroisoquinoline-3-carboxamide scaffold.

Discovery of novel Ebola entry inhibitors with 1,2,3,4-tetrahydroisoquinoline-3-carboxamide based on (3S,4aS,8aS)-2-(3-amino-2-hydroxypropyl) decahydroisoquinoline-3-carboxamide scaffold.

Journal: Bioorganic & medicinal chemistry letters

Published: November 20, 2024

Human milk oligosaccharides and the association with microbiota in colostrum: a pilot study.

Human milk oligosaccharides and the association with microbiota in colostrum: a pilot study.

Journal: Archives of microbiology

Published: October 19, 2023

A prodrug of the capsid assembly modulator improved druggability and lowing HBsAg and HBeAg for the treatment of chronic hepatitis B.

A prodrug of the capsid assembly modulator improved druggability and lowing HBsAg and HBeAg for the treatment of chronic hepatitis B.

Journal: European journal of medicinal chemistry

Published: March 15, 2023

A novel phthalazinone derivative as a capsid assembly modulator inhibits hepatitis B virus expression.

A novel phthalazinone derivative as a capsid assembly modulator inhibits hepatitis B virus expression.

Journal: Antiviral research

Published: February 03, 2023

Identification of an effective fraction from Ampelopsis Radix with anti-dengue virus activities in vitro and in vivo.

Identification of an effective fraction from Ampelopsis Radix with anti-dengue virus activities in vitro and in vivo.

Journal: Journal of ethnopharmacology

Published: November 27, 2022

Synthesis and pharmacological evaluation of choroquine derivatives bearing long aminated side chains as antivirus and anti-inflammatory agents.

Synthesis and pharmacological evaluation of choroquine derivatives bearing long aminated side chains as antivirus and anti-inflammatory agents.

Journal: Bioorganic chemistry

Published: July 22, 2021

CoVac501, a self-adjuvanting peptide vaccine conjugated with TLR7 agonists, against SARS-CoV-2 induces protective immunity.

CoVac501, a self-adjuvanting peptide vaccine conjugated with TLR7 agonists, against SARS-CoV-2 induces protective immunity.

Journal: Cell discovery

Published: July 14, 2021

Psoralen inhibits hepatitis B viral replication by down-regulating the host transcriptional machinery of viral promoters.

Psoralen inhibits hepatitis B viral replication by down-regulating the host transcriptional machinery of viral promoters.

Journal: Virologica Sinica

Published: May 30, 2021

Discovery of Phthalazinone Derivatives as Novel Hepatitis B Virus Capsid Inhibitors.

Discovery of Phthalazinone Derivatives as Novel Hepatitis B Virus Capsid Inhibitors.

Journal: Journal of medicinal chemistry

Published: July 22, 2020

Treatment of Chronic Hepatitis B Virus Infection Using Small Molecule Modulators of Nucleocapsid Assembly: Recent Advances and Perspectives.

Treatment of Chronic Hepatitis B Virus Infection Using Small Molecule Modulators of Nucleocapsid Assembly: Recent Advances and Perspectives.

Journal: ACS infectious diseases

Published: March 22, 2019

Showing 1-12 of 14

Last Updated: 09/26/2026